JRBiomedical's Milenia S-100B point-of-care test is used as a marker of brain injury and is designed specifically for accident-and-emergency and intensive-care units.
According to the company, integration of the S-100B within existing management routines can reduce the need for CT scans by 30 per cent, resulting in improved and more efficient patient care.
The test is a 20-minute quantitative assay for the measurement of S100bb isoform in whole blood or serum.
Milenia S100B, combined with Milenia IL-6, can also help to identify severe head-injury patients at risk of pneumonia.
The Milenia Quickline system provides anytime access to IL-6 and S-100B measurements in the accident-and-emergency or intensive-care unit.
